Cubist Pharmaceuticals Inc. has named Kenneth M. Bate as non-executive chair of the company’s board. Bate, who takes on the appointment immediately, has been the lead director of the board since mid-2006.
President and CEO of Archemicx Corp., Bate has held a board seat with Cubist since 2003. Prior to taking the position with Archemix in 2009, he worked as president and CEO of Nitromed Inc. He also serves on the boards of AVEO Pharmaceuticals Inc. and BioMarin Pharmaceuticals Inc.